FemTech Conference Circuit Founders Should Know

FemTech spans fertility, reproductive and pelvic health, menopause care, wellness, and preventive services, with market-size figures in this category diverging by tens of billions depending on the source. Research and Markets sizes the 2025 market as $46.47 billion, forecasts $55.88 billion by 2026 on a 20.2% compound trajectory, and projects $118.99 billion for 2030. Market Insights puts 2025 at $66.2 billion, climbing to $73.4 billion by 2026 and reaching $255.5 billion in 2035, with a 14.9% CAGR. Straits Research lines up with Research and Markets, pegging 2025 at $45.58 billion and 2026 at $52.90 billion. The companies aren't off so much as using separate frames: FemTech can include diagnostics, scoping clinical tools, user apps, or a three-part blend, and when a founder repeats a single figure without context, they're signaling which audience has shaped their pitch. America tops the regional market with 49.08%, Asia Pacific's 18.44% CAGR is the fastest pace, and that matters more than it seems when a founder picks where to put conference money.

Where FemTech money is heading, and what it signals to founders about which rooms matter

Category Funding arrives in bursts, not as a drip. FemTech startups focused on PCOS, endometriosis, and maternal care pulled in $72 million during March 2026. EverythingStartups says that, in April 2026, 17 startups spanning AI-powered diagnostics, health, and fertility tech took in $674 million, a genuinely outsized sum. That kind of swing from one month to the next tells founders something plain: timing a raise around "the market being hot" is a bad plan, because the market is hot in patches, not in general.

Tracing that money to its destination makes the situation sharper and far from forgiving. During the year through June 2026, Women's Primary Care, Hormonal Health Platforms, and Fertility Care Platforms together captured 94.01% of disclosed FemTech capital across 23 unique companies in 23 disclosed rounds. Hormonal Health Platforms raised 6 deals worth a substantial sum. A comparably large sum went to Fertility Care Platforms in 5 deals. Menstrual Health Tools landed only 3 deals worth a much smaller sum, a shortfall beyond rounding that reveals where investor bets currently go.

That same narrow focus applies to the investors. Only 7 investors crossed into multiple disclosed rounds over that stretch: the thesis-driven money here is a tight, identifiable circle. For a founder, this is the ballgame: a crowd of generalist investors matters much less than a table with 3 specialists who've already made a hormonal-health investment this year. Figuring out which rooms have those specialists, rather than just the packed ones, is what really drives every conference signup.

How to size up a conference before you sign up: four variables that shape what it can do for you

Every FemTech conference sells itself on scale, speaker lists, and vague promises of "access." None of that tells a founder what the event can actually do for them. Four factors will.

Start with the audience: who’s actually there. Payers and health decision-makers need one pitch, investors another, and a clinician or pharma BD person is after a third. When someone from government is in the audience, everyone talks differently. A founder needs the real breakdown before registering.

Structured, time-blocked meetings beat ambient networking, but people keep underpricing that gap. Pre-scheduled one-to-one meetings and pitch competitions, plus demos, lead to results that can be tracked: people met, a pitch was given, a follow-up note arrived or it didn't. Loose networking, the drinks and badge-scanning sort, creates a sense of progress that isn't really there. Founders watching their money should have organizers break down how much of the day's time is structured versus ambient before buying a plane ticket.

Location drives the rules, so it's no side issue. A conference tied to a country’s gynaecology and obstetrics group will orient around that health service's setup, local reimbursement, and clinical rules. A regional forum put together by regional FemTech groups will follow local rules and tackle cross-border market entry issues. A Boston summit built around payers and US employers follows a different rulebook. The pitch a founder carries into one setting needs rebuilding to land in another.

Start with stage fit. For an early-stage founder, visibility and investor introductions matter more than nearly anything else. One at growth stage needs business deals and payer ties, a separate crowd even at the same conference. Some events genuinely cover both stages of that range effectively. Most fail to, and acting like they do wastes a founder's scarcest asset, not cash but their schedule.

Women's Health Innovation Summit (WHIS), October 13-15, 2026, Encore Boston Harbor, Everett, MA

WHIS, organized by Kisaco Research, is back for its eighth run, projecting 1,000+ top executives spanning payers, pharma, health investors, policymakers, and more. It bills itself as a leading innovation meetup for people building, funding, and shaping women's health, now in its eighth edition.

The agenda spans four streams covering key stages of the innovation lifecycle. That setup matters specifically for stage fit. A founder with a clinical hypothesis still validating it and a founder negotiating payer terms can both fit here, unlike every gathering on this circuit.

Women's Health and FemTech Conference 2026, October 21, 2026, Royal College of Obstetricians and Gynaecologists, London

Run by an events outfit with a £399 early-bird ticket plus VAT, this single-day meeting sends a clear message just from where it's held. The venue alone, at London's Royal College of Obstetricians and Gynaecologists buys credibility among NHS and clinical circles before any speaker steps on stage.

The agenda starts with a keynote about the UK Women's Health Strategy in England, looking at how wide health inequalities stretch and what remains to be done, featuring speakers including Dame Lesley Regan of Wellbeing of Women alongside Kate Lancaster of RCOG. It then turns to a panel on banning and censorship, with Anna O'Sullivan of CensHERship examining how gender bias is baked into algorithms and hurts women's health companies seeking people on the web.

After that, a panel on clinical research brings together Tina Backhouse, Sarita Stefani from Amilis, plus Rowan Miller of the London Clinic to discuss persistent gaps across women's health and how doctors fix them with real patients instead of just publishing findings. Building a clinic gets its own panel, featuring speakers including Richard Bentley of MSI Reproductive Choices alongside Nicola Aspinall of London Gynaecology, tackling care, accessibility, and the financial realities of keeping a women's health clinic going. A FemTech and online clinic panel closes the programme, with Mary O'Reilly of MOR Advisory, 28X, Dr. Sujitha Selvarajah of Hesta Health, and Lily Elsner of Jack Fertility on closing care gaps: paths to market, partnership models, funding, and what real growth needs.

The audience spans solo doctors, clinics focused on women's health, NHS bodies, insurers, HR staff handling perks, FemTech founders and investors, plus regulators, policymakers, clinicians: a big crowd for one single-day program, yet the RCOG space holds the clinical and rules talk anchored instead of diffuse.

Women's Health Europe Forum, November 27, 2026, Handilab, Paris

Run by Femtech France with Delphine Moulu at the helm, the forum positions itself as a key gathering in women's health innovation. An inaugural gathering carries a clear upside for founders: they face lighter fights for visibility, skip the old cliques, and find openness from organizers who want it to work.

The event is being kept small: about 200 attendees on site, more than 200 joining by video, and over 50 one-to-one sessions set across the agenda. For a debut gathering, that share of one-to-ones to guests is notable, and it reflects the forum's built-in access: someone showing up can actually meet the right contact, not just trade names.

But what makes this forum different is the group running it. The forum is supported by FemTech Portugal, FemTech Spain, FemTech Germany, FemTech NL, FemTech Across Borders, and Tech4Fem. One session in Paris connects multiple distinct ecosystems simultaneously. For a founder working out market entry across a nearby bloc without hopping around five countries, it’s genuinely time well spent.

FemTechConf Women in Tech EMEA Summit, October 29-30, 2026, smartvillage Berlin

FemTechConf, a training organization approved by the EU with over 450,000 members globally, organizes this two-day summit expecting 1,250+ attendees and 18+ speakers, using a single-track setup so everyone stays in the same room for each session instead of splitting across parallel tracks.

The opening program is more about work paths and leading in tech than health or funding: with Yordanova of DKB Code Factory, Delivery Hero’s Nikita Menon, and Meta’s Soukayna Ikhiche on image and getting ahead for women. Sinha of Miro argues for changing the structures themselves so women don't have to fit in, and Ana Pasparan of Vodafone discusses AI as a career multiplier. Anna Fill from paricon focuses on personal growth before expanding a company, while Asia Sharif of NatWest shares how she went from learning to code on her own to creating money tools that serve everyone.

The summit closes with a VIP afterparty hosted alongside AWS, featuring networking opportunities. Take this gathering at face value: a solid place to meet people, share career stories, and get wider visibility for women in tech, set apart from the clinical or finance-focused conferences on this list.

Femtech Connect 2026, Edmonton, Canada (Brighton Block, 9666 Jasper Ave)

Antigoni Studios Ltd. organized it. It went up on Luma and has already happened, a detail that matters to any founder reading this to map out what's next. It appears here because it fills in how the FemTech circuit operates beyond its main hubs.

Framed as a summit that would amplify evidence-based innovation, it sought to connect people building what organizers billed as a new standard in women's health while steering where FemTech heads next. That framing, regardless of what the agenda covered, shows what the wider circuit confirms: FemTech's conference scene is spreading geographically at the rate funding says the category itself grows, and any founder plotting eighteen months out needs routes outside Boston, Paris, London, and Berlin.